Whether the AHR is involved in BIA-ALCL pathogenesis remains to be seen, but given that BIA-ALCL is considered a malignancy of Th17/Th1 T-cell subsets, it is not improbable [29,51–53]. This evidence concerns the gene AHR and anaplastic large cell lymphoma.